Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

New England Journal of Medicine

Volumn 337, Issue 3, 1997, Pages 161-167

  Bosset, Jean François ^a   Gignoux, Marc ^a   Triboulet, Jean Pierre ^c   Tiret, Emmanuel ^d   Mantion, Georges ^b   Elias, Dominique ^e   Lozach, Patrick ^f   Ollier, Jean Claude ^g   Pavy, Jean Jacques ^a   Mercier, Mariette ^a   Sahmoud, Tarek ^h   Séol, Philippe ^b   Flamant, Jean Bernard ⁱ   Arnaud, Jean Pierre ^j   Plachot, Jean Pierre ^k   Mandard, Anne Marie ^l   Chaillard, Gaelle ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b CHU CÔTE DE NACRE   (France)

^c Claude Hurriez University Hospital   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f CHU MORVAN   (France)

^g University Hospital   (France)

^h EORTC DATA CENTER   (Belgium)

ⁱ SERVICE DE DERMATOLOGIE   (France)

^j ANGERS UNIVERSITY HOSPITAL   (France)

^k AMIENS UNIVERSITY HOSPITAL   (France)

^l CENTRE FRANÇOIS BACLESSE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GASTRECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0030793423     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199707173370304     Document Type: Article

References (41)

1. Bedenne L, Faivre J, Boutron M-C, et al. Le cancer de l'oesophage dans le département de la Côte-d'Or. Bull Cancer 1986;73:526-34.
2. Chérié-Challine L, Pottier D, Gignoux M. Épidémiologie descriptive du cancer de l'oesophage dans le département du Calvados: 520 cas (1978-1982). Gastroenterol Clin Biol 1988;12:126-32.
3. Calament G, Cauvin J-M, Robaszkiewicz M, et al. Traitement et survie du cancer épidermoïde de l'oesophage dans le département du Finistère entre 1984 et 1988 (716 cas). Gastroenterol Clin Biol 1993;17:9-16.
4. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265: 1287-9.
5. Siewert JR, Fink U, Beckurts KTE, Roder JD. Surgery of squamous cell carcinoma of the esophagus. Ann Oncol 1994;5:Suppl 3:1-7.
6. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma. I. A critical review of surgery. Br J Surg 1980;67:381-90.
7. Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-57.
8. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994;81:410-3.
9. Aisner J, Forastiere A, Aroney R. Patterns of recurrence for cancer of the lung and esophagus. Cancer Treat Symp 1983;2:87-105.
10. Tam PC, Siu KF, Cheung HC, Ma L, Wong J. Local recurrences after subtotal esophagectomy for squamous cell carcinoma. Ann Surg 1987;205: 189-94.
11. Sugimachi K, Inokuchi K, Kuwano H, Kai H, Okamura T, Okudaira Y. Patterns of recurrence after curative resection for carcinoma of the thoracic part of the esophagus. Surg Gynecol Obstet 1983;157:537-40.
12. van Lanschot JJB, Tilanus HW, Voormolen MHJ, van Deelen RA. Recurrence pattern of oesophageal carcinoma after limited resection does not support wide local excision with extensive lymph node dissection. Br J Surg 1994;81:1320-3.
13. Law SYK, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 1996;83:107-11.
14. Fink U, Stein HJ, Bochtler J, Roder JD, Wilke HJ, Siewert JR. Neoadjuvant therapy for squamous cell esophageal carcinoma. Ann Oncol 1994;5:Suppl 3:17-26.
15. Gignoux M, Bosset JF. Adjuvant therapy for resectable oesophageal cancer: results of a pilot study. Anticancer Res 1989;9:1023-4.
16. Wurtz A, Quandalle P, Chambon JP, Saudemont A, Chastanet P, Robert Y. Corrélations entre diamètres mesurés par tomodensitométrie et extension intra-pariétale des carcinomes malpighiens de l'oesophage thoracique: a propos de 101 confrontations anatomo-radiologiques. J Chir 1990;127:63-7.
17. Dose specification for reporting external beam therapy with photons and electrons. ICRU report 29. Washington, D.C.: International Commission on Radiation Unit and Measurements, 1978.
18. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer 1994;73:2680-6.
19. Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1982;1:121-9.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
21. Mantel N. Evaluation of survival and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
22. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-220.
23. Launois B, Delarue D, Campion JP, Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981;153: 690-2.
24. Gignoux M, Roussel A, Paillot B, et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 1987;11:426-32.
25. Wang M, Gu XZ, Yin WB, Huang GJ, Wang LJ, Zhang DW. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 1989;16:325-7.
26. Arnott SJ, Duncan W, Kerr GR, et al. Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 1992;24:108-13.
27. Tenière P, Hay JM, Fingerhut A, Fagniez P-L. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991;173:123-30.
28. Fok M, Sham JST, Choy D, Cheng SW, Wong J. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993;113:138-47.
29. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988;96:242-8.
30. Schlag P. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 1992;127:1446-50.
31. Fok M, Wong J. Prospective randomized study of preoperative chemotherapy in the treatment of resectable esophageal carcinoma. In: Abstract book of the Fifth World Congress of the International Society for Diseases of the Esophagus, Kyoto, Japan, 1992:149.
32. Kok T, Tilanus H, Obertop H, et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: an interim report of a randomized controlled trial. In: Abstract book of the Fifth World Congress of the International Society for Diseases of the Esophagus, Kyoto, Japan, 1992:38.
33. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy: the second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-10.
34. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-84.
35. Urba S, Orringer M, Turrisi A, et al. A randomized trial comparing transhiatal esophagectomy to preoperative concurrent chemoradiation followed by esophagectomy in loco regional esophageal carcinoma. Proc Am Soc Clin Oncol 1995;14:475. abstract.
36. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7.
37. von der Maase J, Overgaard J, Vaeth M. Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice. Radiother Oncol 1986;5:245-57.
38. Giri PGS, Kimler BF, Giri UP, Cox GG, Reddy EK. Comparison of single, fractionated and hyperfractionated irradiation on the development of normal tissue damage in rat lung. Int J Radiat Oncol Biol Phys 1985; 11:527-34.
39. Van Dyk J, Mah K, Keane TJ. Radiation-induced lung damage: dose-time-fractionation considerations. Radiother Oncol 1989;14:55-69.
40. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:457-67.
41. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.